In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. - Wikidata - awgldk - TriplyDB

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

http://www.wikidata.org/entity/Q42015621

about

Src family kinases and HER2 interactions in human breast cancer cell growth and survival.Optimizing antimetabolite-based chemotherapy for the treatment of childhood acute lymphoblastic leukaemia.Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.Prediction of individual response to anticancer therapy: historical and future perspectives Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells.Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97.Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity.Glucocorticoid resistance in childhood leukemia.Cellular drug resistance in childhood leukemia.Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells.In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development.Increased in vitro cellular drug resistance is related to poor outcome in high-risk childhood acute lymphoblastic leukaemia.In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci.Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.Assessment of mercaptopurine (6MP) metabolites and 6MP metabolic key-enzymes in childhood acute lymphoblastic leukemia.Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia.Parameters affecting the ex vivo cytotoxic drug sensitivity of human hematopoietic cells.Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.

P2860

Q30307291-3DBB4665-E843-4B10-9B56-DCEBCF80DD18 Q33994352-05A1825E-2405-4803-9927-6B230868ACE1 Q34071693-10282D8E-4D1B-4029-BECC-F7CB86BD76F8 Q35024682-DC0B7051-D78B-42A8-962C-BBB0D5E9B831 Q35994527-38BEF288-BDD3-4668-8256-908840029288 Q38293997-A58BCCD7-719F-40F0-86CB-7EFA5C4C6DA4 Q39205653-FD0C4E7E-18A1-43BE-8057-F850684846E6 Q39521576-68D359C4-5C89-4984-A2A4-211F249FD76E Q39918490-91EFFB05-2BCA-4B3E-BDC2-A32680AB5954 Q40486495-0DCE9613-2F0A-440D-AA1A-EFB6D202175E Q40486579-6CA4464A-0C78-40CC-ABE9-92D67D2E40FD Q40682800-6F4CEB7D-A7D9-4AEA-946D-BE90D846D189 Q40689264-1CE61E35-C46E-45BC-91FB-A5E7F166E1EA Q40967236-5EA18A27-927F-483B-BE47-01AEF066853B Q41337826-059F8015-1C54-49CC-8209-AC17EC4368C6 Q42032841-669B3482-5047-4B30-ADD1-9D22F48CE9D9 Q42281472-EA6B2DE4-605D-41FA-8FA0-370AA6C27965 Q42725619-D2EEF016-516D-4B51-BBFE-7544D96B33DD Q43548665-AD688A13-E689-4B26-9B1C-CA315CADC9CA Q43976754-3D097274-A0E9-42D3-B58F-77895471E314 Q44497842-A2B86BE0-F4EE-429E-A28C-53949ACB531A Q44523391-9BB6F281-1B51-4BD4-8C2E-CC90274D976B Q44719683-EC039BD7-427D-4C32-A74A-423127D34C9C Q45310201-58909DF4-DF5B-462E-B746-7FC21D785467 Q46424987-04A36142-B6DC-4E5E-A076-A3BDA17B356C Q46793120-1A49C34A-396B-49B8-B8CC-B175F4BDE994 Q50537461-9EC1E9B7-D6E2-4821-BC4C-CF0150302F51 Q50758858-351E30AC-1616-454E-9627-31561F3F8780 Q53951493-B10F6D25-BB1D-406E-B807-3B0118CC62E6 Q54072981-0D17E77A-D5D6-4BBE-A932-2C92D74B8E62 Q54219263-117D5FCD-A158-42C4-BEAD-A89E76F3BF14

P2860

In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

http://www.wikidata.org/entity/Q42015621

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@en

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@nl

type

label

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@en

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@nl

prefLabel

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@en

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@nl

P1433

Q42015621-D6F0FDCE-77E1-4055-91C6-400C2F2F6561

P1476

Q42015621-7391EE7A-B2FD-4928-B0CA-6EBBAD9C2900

P2093

Q42015621-04C97209-AB0E-41A2-A0CA-A859EF5823FE

Q42015621-12D30125-3A1B-4744-AC19-66E520BB4406

Q42015621-529E8948-A31D-449A-A75C-7FCB954D4B23

Q42015621-56B1A850-EB0E-4CA3-9FA2-0898AA802C9F

Q42015621-6E0B1B5C-A221-4C9F-8F33-936EB042D0D6

Q42015621-BEFE43ED-B4BC-4E2A-8AF9-14F3F6A21EA5

Q42015621-CC28B373-F249-4346-B361-C3D51C18C392

P2860

Q42015621-2167130B-AD0D-429B-B861-1F9429D1CB68

Q42015621-2C403125-AF3A-4DDC-9E37-6358F7D7CA93

Q42015621-2DB46E0B-8F81-4BFD-8092-1103A07CFF9C

Q42015621-4DCA3802-3ADD-4946-B472-B641172EC6C2

Q42015621-5DA7E00D-51EB-46F2-9B76-BE6A09CF5573

Q42015621-5E8E3BE7-FB2D-4178-BB15-80571A2CBA49

Q42015621-90BE2E66-2B94-44CD-BE2C-FB77234819CB

Q42015621-9F241920-8C18-4326-80D0-132E5109C9DD

Q42015621-A53F34C6-8C6F-4FBD-989E-ED0EBBFCC34D

Q42015621-B0A7F2DA-BDD0-420D-AC72-9CDE5F2053BF

P2888

Q42015621-3A6BDBCE-514A-42A7-BD21-CA1C400C98F9

P304

Q42015621-9D8E7599-EBB1-4353-9F35-41C18D2F4A10

P31

Q42015621-9A7E3267-AEE9-497A-BBA8-BBF4BA6D727C

P356

Q42015621-C92EB1AC-7475-4D23-996B-D4E41B11BC23

P407

Q42015621-BCDFBC2B-58A7-4E09-BF9A-CCCF709AB45F

P433

Q42015621-68941C2E-466A-406D-8005-7B73B6064DE5

P478

Q42015621-997380C4-452A-497D-9285-A2781B51E18E

P577

Q42015621-D36F93BF-C1F2-40C1-8279-C2DEAEC7B098

P5875

Q42015621-0782A4E5-35D5-46C6-A3B2-92835DC6FBA0

P698

Q42015621-1483F94A-6DEB-408C-8145-BD49D768590A

P921

Q42015621-91253E5D-C2E0-4749-B6A7-370B151FB516

Q42015621-C5E70773-F897-4A52-ACF8-93ED42393E2C

P932

Q42015621-709F3979-0CB2-43B9-8314-27C21E48A3BD

P356

P1433

British Journal of Cancer

P1476

In vitro drug sensitivity of n ...... e marrow and peripheral blood.

@en

P2093

De Laat PA

http://www.w3.org/2001/XMLSchema#string

De Waal FC

http://www.w3.org/2001/XMLSchema#string

Kaspers GJ

http://www.w3.org/2001/XMLSchema#string

Pieters R

http://www.w3.org/2001/XMLSchema#string

Van Wering ER

http://www.w3.org/2001/XMLSchema#string

Van Zantwijk CH

http://www.w3.org/2001/XMLSchema#string

Veerman AJ

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

The influence of sample source and cell concentration on the in vitro chemosensitivity of haematological tumours

Drug sensitivity assays in leukaemia and lymphoma.

Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.

A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.

Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.

Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C.

L-asparaginase: toxicity to normal and leukemic human lymphocytes.

P2888

P304

469-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1991.333

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

1991-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21245175

http://www.w3.org/2001/XMLSchema#string

P698

1911186

http://www.w3.org/2001/XMLSchema#string

P921

P932

1977664

http://www.w3.org/2001/XMLSchema#string